IMDx Licenses Biosearch Probe Patents; Will Use IP to Develop MDx Assays with Abbott
March 17, 2011
IMDx Licenses Biosearch Probe Patents; Will Use IP to Develop MDx Assays with Abbott
Biosearch has granted a license to IMDx for patents related to Biosearch's fluorophores and dark quencher dyes; and will manufacture cGMP oligonucleotides for IMDx for use in PCR-based human in vitro diagnostics, including those being developed in partnership with Abbott.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Biosearch Licenses Dye IP to DuPont Qualicon; Will Make Primers for DuPont's Food-Testing Platform
October 28, 2010 / PCR Insider - Qiagen Looks to IMDx to Accelerate Test Menu Development for QiaSymphony RGQ Platform
January 10, 2013 / PCR Insider - Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
August 4, 2011 / PCR Insider - Dx Focus: Luminex, BD Diagnostics, Diagenode, BioFire Diagnostics, IMDx
April 18, 2013 / PCR Insider - Abbott, Astellas Using m2000 to Test Patient Viral Load in CMV Vaccine Trial
September 6, 2012 / PCR Insider